$13.46 -0.09 (-0.66%)
11/6/2009 4:00 PM

ISIS Pharmaceuticals, Inc. (ISIS)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Current Price $13.46 Mkt Cap $1.32B
Open $13.42 P/E Ratio 920.50
Prev. Close $13.55 Div. (Yield) N/A (N/A)
Daily Range $13.29 - $13.74 Volume 1,150,027
52-Wk Range $9.90 - $18.81 Avg. Daily Vol. 1,071,000

ISIS News and Commentary

Caps

How do you think ISIS will perform vs the S&P 500?

Add Stock to Watchlist

All Members

473 Outperform
27 Underperform
 

All-Star Members

90 Outperform
8 Underperform
 

Wall Street

14 Outperform
0 Underperform
 

Top ISIS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Teknowizz (90.41)
Submitted August 04, 2009

Nice pipeline (http://www.isispharm.com/Pipeline/index.htm) of antisense (SiRNA) drugs, which they partner or license for commercialisation. Several drugs for multiple indications in P3. Cashflow is OK, likely to become profitable by end of year or… More

Paramnesia1930 (97.08)
Submitted July 31, 2009

The 1929-1930 equity rally (coming out of The Great Depression) lasted 147 days and the market was up 46%. It has been the same amount of time since the March, 2009 low and we are up about the same percentage. It’s déjà vu (paramnesia), so… More

ISIS VS S&P 500 (SPY)

Fools bullish on ISIS are also bullish on:

Fools bearish on ISIS are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about ISIS.

Recs

0
Member Avatar JerryDreamer (< 20) Submitted: 8/17/2009 1:48:04 AM : Underperform Start Price: $15.37 ISIS Score: +21.32

When the overly optimistic FOMC says that household spending will be "constrained" by sluggish income growth, ongoing job losses, lower household wealth, and tight credit AND Shanghai stocks hit a seven-week low, then you know this bear market rally is finally over!

Recs

1
Member Avatar Teknowizz (90.41) Submitted: 8/4/2009 6:01:43 PM : Outperform Start Price: $18.68 ISIS Score: -34.77

Nice pipeline (http://www.isispharm.com/Pipeline/index.htm) of antisense (SiRNA) drugs, which they partner or license for commercialisation. Several drugs for multiple indications in P3. Cashflow is OK, likely to become profitable by end of year or sometime in 2010. They already have lot's of income even from drugs not already marketed due to license (of IP, have 1600 patents) & milestone payments.

Recs

1
Member Avatar Paramnesia1930 (97.08) Submitted: 7/31/2009 7:06:44 PM : Underperform Start Price: $18.32 ISIS Score: +34.30

The 1929-1930 equity rally (coming out of The Great Depression) lasted 147 days and the market was up 46%. It has been the same amount of time since the March, 2009 low and we are up about the same percentage. It’s déjà vu (paramnesia), so prepare for a drop of about the same percentage (85%).

Leaderboard

Find the members with the highest scoring picks in ISIS.

Score Leader

princemot

princemot (42.62) Score: +119.04

The Score Leader is the member with the highest score across all their picks in ISIS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
Santa22 < 20 9/22/2006 Outperform 3Y $7.02 +91.74% -13.37% +105.10
asterionc2 79.96 9/27/2006 Outperform 5Y $7.10 +89.58% -14.77% +104.35
jdmckeehan < 20 10/2/2006 Outperform 3Y $7.18 +87.47% -14.83% +102.30
leadtip 60.42 8/25/2006 Outperform 1Y $7.09 +89.84% -11.86% +101.71
gsstock 63.70 8/23/2006 Outperform 5Y $7.14 +88.52% -12.29% +100.81
John8464 < 20 9/15/2006 Outperform 1Y $7.23 +86.17% -14.34% +100.50
schmosly 28.40 10/3/2006 Outperform 1Y $7.31 +84.13% -14.79% +98.92 1 Comment
stanhutchings < 20 8/28/2006 Outperform 5Y $7.20 +86.94% -11.92% +98.87 1 Comment
mcgoatcheese 91.25 9/8/2006 Outperform 5Y $7.58 +77.57% -12.40% +89.97
Unklesam101 45.29 5/31/2006 Outperform 3Y $7.60 +77.06% -9.92% +86.98 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCantorFitz 25.13 7/29/2009 Outperform NS $17.87 -24.68% +10.48% -35.15
TrackJimCramer < 20 3/16/2009 Outperform 3W $13.57 -0.81% +43.72% -44.53
TrackMorganJos < 20 1/9/2009 Outperform NS $14.41 -6.59% +19.60% -26.19
TrackJimCramer < 20 1/6/2009 Underperform 3W $14.86 -8.68% -18.84% -10.16 3/16/2009 @ $13.57
TrackCollinsStew 68.32 12/16/2008 Outperform NS $11.25 +19.64% +24.47% -4.82
TrackZacks 69.52 11/11/2008 Outperform 3M $15.12 -10.98% +22.43% -33.41 1 Comment
TrackJimCramer < 20 8/27/2008 Outperform 3W $17.73 -16.19% -27.33% +11.15 1/7/2009 @ $14.86
TrackWachovia 35.10 10/11/2007 Outperform NS $16.02 -15.98% -28.48% +12.50
TrackWIG 91.78 10/1/2007 Outperform 3Y $14.95 +16.19% +1.01% +15.18 10/16/2007 @ $17.37
TrackEveillard 89.92 9/30/2007 Outperform NS $14.97 +5.21% -4.17% +9.39 12/31/2007 @ $15.75 1 Comment
TrackJefferies 75.83 7/19/2007 Outperform NS $11.33 +18.80% -27.34% +46.14
TrackNeedham < 20 7/9/2007 Outperform NS $10.60 +26.98% -26.37% +53.35
TrackTobinSmith < 20 6/22/2007 Outperform 1Y $9.53 +41.24% -25.11% +66.35
TrackZacks 69.52 6/7/2007 Outperform 3M $9.16 +55.13% -33.73% +88.86 10/20/2008 @ $14.21 1 Comment
TrackFortisBank 86.13 3/20/2007 Outperform NS $8.93 +50.73% -19.31% +70.04
TrackLehmanBros 76.60 1/29/2007 Outperform NS $11.06 +21.70% -20.03% +41.73
TrackAGEdwards 89.12 11/10/2006 Outperform NS $10.37 +29.80% -17.69% +47.48
TrackCowenandCo 74.62 11/9/2006 Outperform NS $10.19 +32.09% -18.21% +50.30
TrackJimCramer < 20 3/24/2006 Underperform 3W $8.91 +98.99% -1.14% -100.13 8/27/2008 @ $17.73
TrackJimCramer < 20 3/1/2006 Outperform 3W $8.14 +9.46% +0.91% +8.55 3/24/2006 @ $8.91

Featured Broker Partners